Dr. Hinanit Koltai joins us and shares what she's finding in phytocannabinoid research. "Not all compounds- the 400 or so present in cannabis- not all of them are needed to treat all different medical indications. But rather, for example, for colon inflammation we found the certain combination of compounds needed to treat this ailment. And we found and we published that as a scientific paper in an international journal, scientific journal, that did see the psychoactive compound of course is not needed to treat, probably is not needed to treat these patients. But rather reduction of inflammation may be done by a different composition of compounds all present in cannabis." Dr. Koltai notes that her research is able to be done based on the fact that through the Israeli Ministry of Health, she's growing cannabis right at the Volcani Center. "We can play and manipulate growth conditions to lead to different composition of compounds that the plant produces. We develop different extraction methods. Some of them are widely used, but some of them are unique and interesting."
California Cannabis Bureau Chief Lori Ajax returns for an update on the industry realities post July 1. She shares that the Bureau is listening to the industry and making adjustments as they go to ensure a healthy marketplace. She notes how important it is to participate in public comment to ensure your voice is listened to, heard and receives a response.
US Congressman Darren Soto joins us and gives us his thoughts on Florida and Federal cannabis policy. He also shares how his thoughts on states rights affect more local policy, "I do believe in local rule, and certain counties and cities should have the character that they've traditionally had, and this may be something they feel is inconsistent with it. Others embrace it. So I get that part of it. I just worry about how different Floridians have different access to one particular type of medicine when with every other type- they're not restricted by geography." And also how those same thoughts might affect federal policy, "we're in the Stone Age here in Congress, so if we even can get that done it would be a step in the right direction. But our main goal is to ratify and give legal cover to the various marijuana legal regimes throughout the United States based upon the different state laws."
Recorded before any mention of resignation- or reasoning for that resignation- US Congressman Tom Garrett joins us and shares what sound like sensible measures in addressing legal cannabis in the United States of America. Further Congressman Garrett discusses the importance of uniformly enforcing the law- tipping his cap to the fact that institutional racism exists and even stating that racial prejudice is at work. He speaks of laboratories for democracy in each state. And he speaks of caregivers and patients being able to make decisions for themselves. He also discusses the fact that the United States of America is "peeing away economic opportunity" but not leading or even participating in the cannabis global landscape. And finally he discusses the reform movement in the United States Congress being more about age than party.
Cannabis Caucus member US Congresswoman Dina Titus joins us and gives us her thoughts on cannabis in Nevada which has already generated $30M for the state. She also shares what's happening with cannabis within the walls of congress specifically in committee, "when you go to the Rule's Committee, that's where you offer these amendments, and they just didn't even hear it or didn't even add it." That surprises Representative Titus based on how many issues cross through cannabis, "you talk about taxes, talk about banking, VA use, persecution, Native Americans..." And back home in Nevada, she notes, "if you have a crazy idea in the morning, by afternoon you'll have a lot of people go along with you. So we need to be sure those privacy rights stay in place."